Aberdeen Group
QURE icon

Aberdeen Group’s uniQure QURE Stock Holding History

Aberdeen Group’s Portfolio QURE Stock Details QURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.8M Buy
5,306,386
+1,627,746
+44% +$33M 0.14% 134
2025
Q4 		$88M Buy
3,678,640
+738,897
+25% +$28.5M 0.14% 132
2025
Q3 		$172M Buy
2,939,743
+189,029
+7% +$3.43M 0.27% 66
2025
Q2 		$38.3M Buy
2,750,714
+535,163
+24% +$7.2M 0.07% 255
2025
Q1 		$23.5M Buy
2,215,551
+706,216
+47% +$9.9M 0.05% 356
2024
Q4 		$26.7M Sell
1,509,335
-419,726
-22% -$3.62M 0.05% 311
2024
Q3 		$9.51M Buy
1,929,061
+1,528,581
+382% +$9.95M 0.02% 531
2024
Q2 		$1.79M Hold
400,480
– – ﹤0.01% 764
2024
Q1 		$2.08M Hold
400,480
– – ﹤0.01% 769
2023
Q4 		$2.71M Buy
+400,480
New +$2.65M 0.01% 752

Other funds holding QURE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return